MEP of the week

Lobby organisation

Federation of European Scleroderma Associations aisbl

NGO / non-profit · Health & pharma · HQ: Belgium · Transparency Register entry

As of 9 September 2026, Federation of European Scleroderma Associations aisbl appears in 8 declared MEP meetings (6 different MEPs), most often with European People's Party.

8
declared meetings
with current MEPs
6
MEPs met
not declared
declared lobbying spend
self-reported to the register
2.0
lobbyists
full time equivalent

In their own words

“The Federation of European Scleroderma Associations (FESCA) aisbl was founded in 2007 and is registered as a charity in Belgium, with a Board drawn from five different EU countries. It is an umbrella group of 27 national scleroderma patient support-and-advocacy organisations in 21 European countries. Our mission is to provide information to people with scleroderma, increase awareness on an international…”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 8 declared meetings, by the meeting MEP's political group.

European People's Party788%
Socialists & Democrats112%

Meetings by year

Declared meetings per calendar year, 2024–2026. Bar length is relative to its busiest year (4 in 2025).

2024
3
2025
4
2026
1

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

András Tivadar Kulja
2 meetings · EPP
Elena Nevado del Campo
2 meetings · EPP
Tomislav Sokol
1 meeting · EPP
Adam Jarubas
1 meeting · EPP
Estelle Ceulemans
1 meeting · S&D

The 8 most recent declared meetings

DateMEPSubject
11 Feb 2026Elena Nevado del CampoINL Rare Diseases
17 Nov 2025András Tivadar KuljaScleroderma situation in Europe
17 Nov 2025Estelle CeulemansMaladies rares
28 Jan 2025Tomislav SokolHealth Policy
16 Jan 2025Oliver SchenkEuropean Health Policy
25 Nov 2024Adam JarubasScleroderma in EU
20 Nov 2024Elena Nevado del CampoScleroderma and rare rheumatic diseases
20 Nov 2024András Tivadar KuljaScleroderma patients in Europe

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.